BIOREM Inc.
BRM.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.47M | 1.53M | 2.29M | 2.00M | 2.23M |
| Total Depreciation and Amortization | 336.90K | 368.80K | 408.00K | 383.80K | 344.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 515.80K | 168.20K | 481.70K | 380.10K | 459.20K |
| Change in Net Operating Assets | 1.06M | -310.50K | 184.40K | 181.40K | -260.50K |
| Cash from Operations | 5.38M | 1.75M | 3.37M | 2.95M | 2.77M |
| Capital Expenditure | -263.30K | -246.80K | -247.00K | -69.70K | -275.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -263.30K | -246.80K | -247.00K | -69.70K | -275.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -682.50K | -666.90K | -724.50K | -707.40K | -729.00K |
| Issuance of Common Stock | 15.50K | 156.90K | 156.90K | 156.90K | 156.90K |
| Repurchase of Common Stock | -100.10K | -100.10K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -549.10K | -436.60K | -407.20K | -396.30K | -421.60K |
| Foreign Exchange rate Adjustments | -152.30K | -386.80K | -63.60K | 114.60K | 139.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.42M | 682.80K | 2.65M | 2.60M | 2.22M |